ERBB2 and KRAS alterations mediate response to EGFR inhibitors in early stage gallbladder cancer

The uncommonness of gallbladder cancer in the developed world has contributed to the generally poor understanding of the disease. Our integrated analysis of whole exome sequencing, copy number alterations, immunohistochemical, and phospho‐proteome array profiling indicates ERBB2 alterations in 40% e...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Int J Cancer
Main Authors: Iyer, Prajish, Shrikhande, Shailesh V., Ranjan, Malika, Joshi, Asim, Gardi, Nilesh, Prasad, Ratnam, Dharavath, Bhasker, Thorat, Rahul, Salunkhe, Sameer, Sahoo, Bikram, Chandrani, Pratik, Kore, Hitesh, Mohanty, Bhabani, Chaudhari, Vikram, Choughule, Anuradha, Kawle, Dhananjay, Chaudhari, Pradip, Ingle, Arvind, Banavali, Shripad, Gera, Poonam, Ramadwar, Mukta R., Prabhash, Kumar, Barreto, Savio George, Dutt, Shilpee, Dutt, Amit
פורמט: Artigo
שפה:Inglês
יצא לאור: John Wiley & Sons, Inc. 2018
נושאים:
Molecular Cancer Biology
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC6378102/
https://ncbi.nlm.nih.gov/pubmed/30304546
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.31916
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים